Health

 News Hour: Sanofi and its vaccines global business unit Sanofi Pasteur announced that 500,000 doses of Dengvaxia® have been received in Paraná to support a large-scale public dengue immunization program initiated  in the State’s 30 most...

News Hour: Strengthening the union level facilities to provide life-saving maternal and newborn care services can significantly improve facility-based deliveries and contribute to reducing maternal and newborn mortality and morbidity in Bangladesh. The observation was made...

News Hour: Seeking medical advice when you notice one of these eight symptoms is the best way to ensure you have another day with your loving family. Don’t overlook these seven signs: 1. Serious back pain...

News Hour: Whether or not they aced the subject in high school, human beings are physics masters when it comes to understanding and predicting how objects in the world will behave. A Johns Hopkins University cognitive...

News Hour: IOM Ghana’s Global Health Security Agenda (GHSA) programme is helping Kotoka International Airport (KIA) to develop a Public Health Emergency Contingency Plan (PHECP) tailored for the operations and capacity of the airport. The formulation...

Women Deliver, a global advocacy organization, awarded seed grants of US$5,000 each to 10 Young Leaders to support digital storytelling projects raising awareness and supporting positive communications in communities about access to contraception and young people’s...

News Hour: Missouri Cancer Associates, the premier cancer treatment center in mid-Missouri and an affiliate of The US Oncology Network, has added another physician to the practice to meet growing demand for its services. Liana Makarian,...

News Hour: Biogen Inc. (NASDAQ: BIIB)  reported second quarter 2016 financial results, including: Total revenues of $2.9 billion, a 12% increase versus the same period in the prior year. Growth was driven by increases in worldwide...

News Hour: The Marketing Authorization Application (MAA) for SB5, an adalimumab biosimilar candidate referencing Humira®, has been accepted for review by the European Medicines Agency (EMA). The MAA for SB5 is the third anti-TNF biosimilar candidate...

News Hour: The European Commission (EC) has granted marketing authorization for ZINBRYTA™ (daclizumab) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), Biogen (NASDAQ: BIIB) and AbbVie (NYSE: ABBV) announced last month....